183 related articles for article (PubMed ID: 35119691)
1. Surgery and Adjuvant Therapy Improve Derkay Scores in Adult and Pediatric Respiratory Papillomatosis.
Hock K; Kennedy A; Howell R; Friedman A; de Alarcon A; Khosla S
Laryngoscope; 2022 Dec; 132(12):2420-2426. PubMed ID: 35119691
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
Ablanedo-Terrazas Y; Estrada-Camacho O; Alvarado-de la Barrera C; Ramírez-García A; Tona-Acedo G; Bross-Soriano D; Schimelmitz-Idi J
Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(2):82-88. PubMed ID: 35397828
[TBL] [Abstract][Full Text] [Related]
3. Surgical outcome of different surgical modalities for adult recurrent respiratory papillomatosis.
Liu S; Shao J
Acta Otolaryngol; 2023 Feb; 143(2):196-200. PubMed ID: 36694999
[TBL] [Abstract][Full Text] [Related]
4. Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.
Bertino G; Pedretti F; Mauramati S; Filauro M; Vallin A; Mora F; Crosetti E; Succo G; Peretti G; Benazzo M
Acta Otorhinolaryngol Ital; 2023 Apr; 43(Suppl. 1):S111-S122. PubMed ID: 37698108
[TBL] [Abstract][Full Text] [Related]
5. Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children.
Rogers DJ; Ojha S; Maurer R; Hartnick CJ
JAMA Otolaryngol Head Neck Surg; 2013 May; 139(5):496-501. PubMed ID: 23681032
[TBL] [Abstract][Full Text] [Related]
6. High-dose sublesional bevacizumab (avastin) for pediatric recurrent respiratory papillomatosis.
Sidell DR; Nassar M; Cotton RT; Zeitels SM; de Alarcon A
Ann Otol Rhinol Laryngol; 2014 Mar; 123(3):214-21. PubMed ID: 24633948
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
Ablanedo-Terrazas Y; Estrada-Camacho O; Alvarado-de la Barrera C; Ramírez-García A; Tona-Acedo G; Bross-Soriano D; Schimelmitz-Idi J
Acta Otorrinolaringol Esp (Engl Ed); 2021 Jun; ():. PubMed ID: 34154795
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
Karatayli-Ozgursoy S; Bishop JA; Hillel A; Akst L; Best SR
Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):235-41. PubMed ID: 26453486
[TBL] [Abstract][Full Text] [Related]
9. Anatomic Derkay Score Is Associated with Voice Handicap in Laryngeal Papillomatosis in Adults.
Kupfer RA; Çadalli Tatar E; Barry JO; Allen CT; Merati AL
Otolaryngol Head Neck Surg; 2016 Apr; 154(4):689-92. PubMed ID: 26908550
[TBL] [Abstract][Full Text] [Related]
10. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.
Gazia F; Galletti B; Freni F; Bruno R; Sireci F; Galletti C; Meduri A; Galletti F
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
12. Office-Based vs Traditional Operating Room Management of Recurrent Respiratory Papillomatosis: Impact of Patient Characteristics and Disease Severity.
Tatar EÇ; Kupfer RA; Barry JY; Allen CT; Merati AL
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):55-59. PubMed ID: 27658005
[TBL] [Abstract][Full Text] [Related]
13. Use of 532-nm pulsed potassium titanyl phosphate laser and adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children: initial experience.
Maturo S; Hartnick CJ
Arch Otolaryngol Head Neck Surg; 2010 Jun; 136(6):561-5. PubMed ID: 20566906
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab as adjuvant therapy for recurrent respiratory papillomatosis in an infant.
Gates C; Tomboc P; Allison A; Carr M
Int J Pediatr Otorhinolaryngol; 2020 Feb; 129():109762. PubMed ID: 31707187
[TBL] [Abstract][Full Text] [Related]
15. HPV genotype is a prognosticator for recurrence of respiratory papillomatosis in children.
Nogueira RL; Küpper DS; do Bonfim CM; Aragon DC; Damico TA; Miura CS; Passos IM; Nogueira ML; Rahal P; Valera FCP
Clin Otolaryngol; 2021 Jan; 46(1):181-188. PubMed ID: 32869523
[TBL] [Abstract][Full Text] [Related]
16. Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Tjon Pian Gi RE; Ilmarinen T; van den Heuvel ER; Aaltonen LM; Andersen J; Brunings JW; Chirila M; Dietz A; Ferran Vilà F; Friedrich G; de Gier HH; Golusinski W; Graupp M; Hantzakos A; Horcasitas R; Jackowska J; Koelmel JC; Lawson G; Lindner F; Remacle M; Sittel C; Weichbold V; Wierzbicka M; Dikkers FG
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1679-87. PubMed ID: 23377227
[TBL] [Abstract][Full Text] [Related]
17. Sublesional Bevacizumab Injection for Recurrent Respiratory Papillomatosis: Evaluation of Utility in a Typical Clinical Practice.
Hall SR; Thiriveedi M; Yandrapalli U; Zhang N; Lott DG
Ann Otol Rhinol Laryngol; 2021 Oct; 130(10):1164-1170. PubMed ID: 33648353
[TBL] [Abstract][Full Text] [Related]
18. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience.
So RJ; Rayle C; Joo HH; Huang EY; Seiwert TY; Raabe EH; Best SR
Laryngoscope; 2024 Jul; 134(7):3253-3259. PubMed ID: 38525973
[TBL] [Abstract][Full Text] [Related]
19. Intralesional cidofovir vs. bevacizumab for recurrent respiratory papillomatosis: a systematic review and indirect meta-analysis.
Zagzoog FH; Mogharbel AM; Alqutub A; Bukhari M; Almohizea MI
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):601-627. PubMed ID: 37831132
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis.
Ballestas SA; Hidalgo Lopez J; Klein AM; Steuer C; Shin DM; Abousaud M; Schmitt NC; Teng Y; Saba NF; Tkaczuk AT
Laryngoscope; 2023 Oct; 133(10):2725-2733. PubMed ID: 36815602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]